The list ranks drugs by their annual cost for a typical course of therapy and are based on the drugs’ list prices.
The 10 most expensive drugs in the U.S., according to GoodRx:
- Zolgensma (Novartis) — $2,125,000
- Myalept (Amryt Pharma) — $855,678
- Luxturna (Spark Therapeutics) — $850,000
- Folotyn (Acrotech Biopharma) — $779,067
- Soliris (Alexion Pharmaceuticals) — $678,392
- Blincyto (Amgen) — $672,968
- Ravicti (Horizon Therapeutics) — $664,092
- Lumizyme (Sanofi) — $643,243
- Actimmune (Horizon Therapeutics) — $633,325
- Takhzyro (Takeda Pharmaceuticals) — $591,035
More articles on pharmacy:
CMS launches Part D plan to lower insulin costs
15 largest pharmacies in the US
Trump sends list of drug-pricing policy proposals to Capitol Hill
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
